SCHEMBL22181900

SCHEMBL22181900

CC1CC=C2C(=O)N(CCCNc3ccc(-c4ncc[nH]4)cc3)C(=O)c3cccc1c32

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 3/20 0.39
▸ KMT2A Q03164 3/20 0.39
▸ POLB P06746 2/20 0.39
▸ CASP1 P29466 1/20 0.39
▸ ALDH1A1 P00352 2/20 0.36
▸ MAPT P10636 2/20 0.36
▸ HTT P42858 2/20 0.36
▸ HPGD P15428 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ DNMT1 P26358 1/20 0.33
▸ DNMT3L Q9UJW3 1/20 0.33
▸ DNMT3A Q9Y6K1 1/20 0.33
▸ MTOR P42345 3/20 0.33
▸ CCR3 P51677 1/20 0.32
▸ USP1 O94782 1/20 0.31
▸ BTK Q06187 1/20 0.31
▸ KCNH2 Q12809 1/20 0.31
▸ HRH3 Q9Y5N1 1/20 0.31
▸ KDM4E B2RXH2 1/20 0.30
▸ CYP1A2 P05177 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22181927 0.82 MEN1 (0.38) MEN1KMT2APOLBCASP1ALDH1A1
SCHEMBL22181901 0.78 SIRT1 (0.50) MEN1KMT2APOLBALDH1A1MAPT
SCHEMBL22182009 0.75 MEN1 (0.34) MEN1KMT2APOLBCASP1ALDH1A1
SCHEMBL22182063 0.75 DNMT1 (0.38) MEN1KMT2APOLBCASP1ALDH1A1
SCHEMBL22182103 0.75 DNMT1 (0.40) MEN1KMT2APOLBCASP1ALDH1A1
SCHEMBL22181867 0.71 HEXA (0.47) MEN1KMT2APOLBCASP1ALDH1A1
SCHEMBL22181932 0.69 MEN1 (0.43) MEN1KMT2APOLBCASP1ALDH1A1
SCHEMBL24418124 0.63 SIRT1 (0.50) MEN1KMT2APOLBALDH1A1MAPT
SCHEMBL22181914 0.63 SIRT1 (0.55) MEN1KMT2APOLBALDH1A1MAPT
SCHEMBL22181851 0.63 CYP1A2 (0.56) ALDH1A1MTORKCNH2HRH3KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020139291-A1 NAPHTHALIMIDE DERIVATIVES AS ANTI-PARASITIC AGENTS FOR THE TREATMENT OF LEISHMANIASIS AS WELL AS VIRAL, BACTERIAL AND NEOPLASTIC DISEASES ISTANBUL MEDIPOL UNIVERSITESI (TR) 2020-07-02 — — WO disclosed
Send feedback